Company news / Client project

Truking Ingenuity Equipment Supports Oryza Recombinant Albumin Project

Date: 2025-10-17 / Source: Original material

Image from publication

The technological leap from 0 to 1 embodies ingenuity at every stage. Oryza Biotechnology has been sharpening its sword for twenty years, creating the world's first "rice hematopoiesis". recombinant human albumin injection (rice) was approved for listing in July 2025. The company's development also marked the beginning of an important milestone - it became the first company to successfully complete the meeting, receive approval for registration and take the lead in launching release work after the relaunch of the fifth set of Science and Technology Innovation Board standards. As a biopharmaceutical separation and purification service provider, Truking Ingenuity successfully assisted Oryza Biotechnology in establishing the world's first plant-derived recombinant human albumin injection production line, providing the entire project with an intelligent, beacon-centric, end-to-end separation and purification solution. Truking Ingenuity provides dozens of sets of fully automatic 1400/1600mm diameter chromatography column and online liquid dispensing chromatography system, as well as several sets of ultrafiltration systems. Backed by the power of ultra-large-scale equipment, Truking Ingenuity precisely meets users' highest demands for high column efficiency and fast response for online liquid preparation. It leverages advanced manufacturing technologies to effectively translate Oryza Biotechnology's innovative medical technology advances into real-world value, reinvigorating the treatment of patients with global diseases.

Image from publication
Image from publication
Image from publication

Swipe left to see more photosTruking Ingenuity uses high-tech production technology.Efficiently transform Oryza Biotechnology innovation results into real value

The Oryza Biotechnology industrialization project covers a total area of ​​148.68 acres, and the planned total construction area is approximately 113,000 square meters. The company aims to build the world's leading "beacon factory" biopharmaceutical manufacturing facility. Separation and purification are a key part of the main process of this production line. The performance of chromatography equipment directly affects the stability of production and the competitiveness of the product in the market. This project uses online liquid preparation for purification and separation, focusing on two key process metrics: liquid preparation stability time and chromatography column column efficiency.

Online liquid dosing system

Best control algorithm, maximum stability time, defining new industry standards

All buffers required for the chromatography and ultrafiltration processes in this project are prepared using the online liquid preparation module built into the system. The online liquid dispensing system was initially dominated by foreign companies, and the perception stability time was more than 1 minute. However, Oryza Biotechnology requires that the stabilization time be controlled within 20 seconds. This goal defies conventional wisdom and is considered "absolutely impossible." The Truking Ingenuity development team has met this challenge. By optimizing the calculation model, improving the three-dimensional structure and adjusting the control algorithm, after countless days and nights of hard work, the company not only achieved the world's first breakthrough of 20 seconds, but also automatically completed the buffer preparation through built-in algorithms and programs, minimizing the stabilization time and achieving a technological leap that attracted the attention of the industry. In addition, the solution conductivity error is controlled within ±2%, and the pH error is controlled within ±0.1. This technology not only improves liquid preparation efficiency, but also saves more than 200L of buffer solution per production batch, effectively reduces water and energy consumption, and helps Oryza Biotechnology build a green, low-carbon and sustainable industrial base. The success of this technology not only broke the monopoly of foreign products, but also teamed up with Oryza Biotechnology to bring "Made China" to the global stage of biomanufacturing.

Fully automatic chromatography column

Original design and manufacturing, one-click column loading, superior performance

For a chromatography column, the main parameters are the efficiency and symmetry of the column. Truking Ingenuity has independently developed a fully automatic chromatography column without any patent conflicts. Its patented distributor design uses macroscopic means to solve the microscopic particle arrangement problem, and the sample distribution effect into the chromatography column is good. At the same time, it is equipped with fully automatic one-click column packing technology to reduce operation complexity and ensure stable and repeatable column performance.

Image from publication

Set different column packing formulas in the column packing station and select according to different packing types. When packing the column, you only need to enter the height of the column base and the compression ratio to realize fully automatic column packing with one click, which greatly improves the column packing efficiency and process repeatability, ensuring the stability and controllability of the chromatography process.

chromatography and ultrafiltration system

Advanced design improves space utilization and yield

The chromatography system has an integrated all-in-one design that integrates the control valve block and the chromatography system. Compact and reasonable layout perfectly matches the production line space and process requirements, effectively saving plant space and improving workshop space utilization and equipment collaboration. Drawing entirely on experience and lessons learned from previous projects, as well as a thorough understanding of the customer's process, the ultrafiltration system achieved an industry-leading low-volume design and increased product yield.

Image from publication

Truking Ingenuity Biological Corps

Let's make progress together

Empowering Innovation Ecology Chinabiopharmaceuticals

As a member of Chutian's biopharmaceuticals and life sciences industry chain, Truking Ingenuity has been actively involved in the entire project cycle with Truking Technology: from the process design stage, it has worked closely with Oryza Biotechnology to optimize the selection and purification parameters of the chromatographic medium based on the characteristics of the rice seed expression system, and finally realized the fully automated production of recombinant human albumin from rice endosperm to injection. This collaboration not only validates Truking Ingenuity's technological leadership in the separation and purification of complex biopharmaceuticals, but also champions the industrialization of botanical source recombinant protein through deep integration of equipment and technology. While Oryza Biotechnology is rewriting the global plasma replacement therapy landscape with "rice hematopoiesis" technology, Truking Ingenuity uses independent innovative separation and purification equipment as the cornerstone to propel China biopharmaceuticals industry chain towards high-tech development. In the future, the two sides will continue to deepen cooperation to protect the health of patients around the world with more effective solutions, and let the hardware technology intelligently created by China benefit the world.

Image from publication

In the Truking Ingenuity Biology Building.Engineers nervously and orderly assemble and debug equipment.Contributing to the implementation of the Oryza Biotechnology project with high efficiency and high quality.

Oryza Biotechnology and Truking Ingenuity use China's high-end and intelligent "combination strike" to realize the "world dream" of the original being China. Truking Ingenuity will continue to uphold the mission of "letting the global pharmaceutical industry gain wisdom", team up with more outstanding companies, and contribute to building an independent and controlled biopharmaceutical industrial chain.

Image from publication